N/A
N=120
The Impact and Benefit of Physical Activity on Premature Ejaculation
Premature Ejaculation
Bottom Line
View on ClinicalTrials.gov: NCT02844998 ↗Enrolled (actual)
120
Serious AEs
0.0%
Results posted
Sep 2017
Primary outcome: Primary: Premature Ejaculation Diagnostic Tool (Total Score) — 14.5; 13.7; 13.7; 8.9 scores on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- physical activity (Behavioral); dapoxetine 30 mg on demand (Drug)
- Age
- Adult · 18+ yrs
- Sex
- Male
- Sponsor
- Ankara Training and Research Hospital
- Primary completion
- May 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Premature Ejaculation Diagnostic Tool (Total Score) |
14.5; 13.7; 13.7; 8.9; 7.8; 12.8 | — |
| PRIMARY Intravaginal Ejaculatory Latency Time |
36.8; 39.3; 33.8; 181.7; 188.6; 50.3 | — |
Summary
The purpose of this study is to investigate the relationship between physical activity and PE, and determine whether moderate physical activity might delay ejaculation time or be an alternative treatment for PE.
Eligibility Criteria
Inclusion Criteria
- Sexually active, heterosexual patients without regular physical activity or erectile dysfunction, and had a sexual partner for at least six months, and sexual intercourse at least twice a week
Exclusion Criteria
- Use of medications for endocrinological, metabolic, chronic systemic, or psychiatric diseases, use of alcohol or addictive substances, or use of drugs that might affect erection and ejaculation, presence of patients with Peyronie's disease, chronic prostatitis, urethritis, or active urinary tract infection, and absence of regular physical activity or previous treatment for premature ejaculation.
Data sourced from ClinicalTrials.gov (NCT02844998). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.